Merck

Merck

Verified
Merck develops and produces medicines, vaccines, biologic therapies and animal health products

Launch date
Employees
Market cap
$230.6b
Net debt
$134m
Firm valuation
€182.6b (Public information from 2022)
Kenilworth Illinois (HQ)

Financials

Edit
Revenues, earnings & profits over time
USD2016201720182019202020212022E
Revenues-40.1b42.3b46.8b48.0b48.7b57.4b
% growth--5 %11 %2 %1 %18 %
EBITDA-15.1b15.8b19.6b20.6b19.8b24.0b
% EBITDA margin-38 %37 %42 %43 %41 %42 %
Profit-2.6b6.2b9.8b7.1b13.0b15.8b
% profit margin-6 %15 %21 %15 %27 %28 %
EV / revenue-4.2x5.1x5.3x4.8x4.0x3.5x
EV / EBITDA-11.2x13.6x12.6x11.2x10.4x8.4x
  • Edit
DateInvestorsAmountRound
-N/A-
Not yet verified
N/A$600kPost IPO Equity
$356mGrant
Total Funding€323m

Recent News about Merck

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
  • Edit
Peloton Therapeutics
ACQUISITION by Merck May 2019
Acceleron Pharma
ACQUISITION by Merck Sep 2021
Afferent Pharmaceuticals
ACQUISITION by Merck Jun 2016
PatientSafe Solutions
ACQUISITION by Vocera Communications Apr 2021
View 24 more